嗜铬细胞瘤和副神经节瘤中皮质醇分泌的作用:临床与围手术期意义
这项回顾性队列研究纳入2个三级内分泌中心的106例嗜铬细胞瘤和副神经节瘤(PPGL)患者,按1 mg地塞米松抑制试验(DST)结果分为抑制组与非抑制组(以1.8 µg/dL[50 nmol/L]为界)。24.5%的患者DST后皮质醇浓度不被抑制,该组肿瘤更大、糖尿病患病率更高、围手术期并发症更多。作者认为常规DST筛查可能改善术前管理。
要点
- 106例PPGL患者中24.5%存在自主皮质醇分泌(DST后皮质醇不被抑制)。
- 非抑制组肿瘤更大(5.2 vs 4.0 cm),糖尿病更常见(术前50.0% vs 26.8%)。
- 非抑制组围手术期并发症(失血、中转开放手术、住院延长)更频繁(P < .05)。
核心结论
- 约四分之一的PPGL患者存在自主皮质醇分泌,与更大肿瘤、更高糖尿病患病率和增加的围手术期风险相关。
- 作者认为常规DST筛查可能改善术前管理,并为了解皮质醇对PPGL结局的影响提供线索。
研究设计与样本
- 回顾性队列研究,纳入2个三级内分泌中心因嗜铬细胞瘤或副神经节瘤接受肾上腺切除术或肾上腺外手术的患者。
- 共106例患者,按1 mg地塞米松抑制试验(DST)结果分为抑制组与非抑制组(以1.8 µg/dL[50 nmol/L]为界)。
- 分析临床特征、生化标志物、肿瘤特征、围手术期结局和随访数据。
主要发现
- 106例患者中24.5%在DST后皮质醇浓度不被抑制。
- 非抑制组年龄更大(中位年龄66 vs 56岁,P < .001),女性比例更高(84.6% vs 48.8%,P = .001),肿瘤更大(5.2 vs 4.0 cm,P < .05)。
- 非抑制组糖尿病在肾上腺切除/手术前(50.0% vs 26.8%,P < .05)和术后(33.3% vs 12.7%,P < .05)均更常见。
- 非抑制组尿和血浆甲氧基肾上腺素浓度更高、DHEAS浓度更低,心血管疾病更多。
- 非抑制组围手术期并发症(包括失血、中转开放手术和住院时间延长)更频繁(P < .05)。
关键数值与推荐
- 非抑制组定义为1 mg DST后皮质醇高于1.8 µg/dL(50 nmol/L),抑制组为低于该阈值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pheochromocytomas and paragangliomas (PPGLs) are tumors marked by excessive catecholamine secretion. Patients with pheochromocytomas may have elevated plasma glucocorticosteroid concentrations. This study aimed to evaluate the prevalence, clinical implications, and perioperative outcomes of autonomous cortisol secretion in patients with PPGLs. DESIGN: This was a retrospective cohort study conducted across 2 tertiary endocrinology centers, including patients with PPGLs who underwent adrenalectomy or extra-adrenal surgery for paragangliomas. METHODS: Patients were divided based on the 1-mg dexamethasone suppression test (DST) results into suppressive and nonsuppressive groups (above or below 1.8 µg/dL [50 nmol/L]). Data on clinical characteristics, biochemical markers, tumor features, perioperative outcomes, and follow-up were analyzed. RESULTS: Among 106 patients, 24.5% exhibited nonsuppressive cortisol concentrations post-DST. These patients were older (median age: 66 vs 56 years, P < .001), predominantly female (84.6% vs 48.8%, P = .001), and presented with larger tumors (5.2 vs 4.0 cm, P < .05). Diabetes was more common in the nonsuppressive group both before adrenalectomy/surgery (50.0% vs 26.8%, P < .05) and after (33.3% vs 12.7%, P < .05). The nonsuppressive group had higher urinary and plasma metanephrine concentrations, lower DHEAS concentrations, and more cardiovascular diseases. Perioperative complications, including blood loss, conversion to open surgery, and prolonged hospital stays, were more frequent in the nonsuppressive group (P < .05). CONCLUSION: One-quarter of patients with PPGLs exhibit autonomous cortisol secretion, associated with larger tumors, higher diabetes prevalence, and increased perioperative risks. Routine DST screening may improve preoperative management and offer insights into the impact of cortisol on PPGLs outcomes.
引用
- Zawadzka K, Calissendorff J, Rzepka E, et al. The Role of Cortisol Secretion in Pheochromocytomas and Paragangliomas: Clinical and Perioperative Implications. J Clin Endocrinol Metab. 2026. PMID: 40578302. doi:10.1210/clinem/dgaf361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。